pretickt

ALNY news

Alnylam Pharmaceuticals, Inc. · end-of-day data as of Oct 16, 2026

Alnylam Pharmaceuticals, Inc.
ALNY · $31.02B
$231.83-14.7%last 60 sessions · close Oct 16, 2026
$205.48$491.2252 weeks
Buy · 30 analystsPT $374.49 +61.5%
  • P/E vs own-92.9%
  • P/E vs sector+39.1%
  • Target upside+61.5%
  • Off 52w high-52.8%
  • Insiders-$399K
  • FCF yield+1.7%
  • Earnings in13d
  • Trendsideways
  • Sector▲ +16.0%
  • RSI47
  • MA20×50Death 3d ago
  • Volume1.1x
  • Support-4.2%
  • Resistance+1.5%

Last session

  • News

Headlines

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.